Last news
Cheetah Mobile To Report First Quarter 2026 Financial Results on June 10, 2026

Cheetah Mobile To Report First Quarter 2026 Financial Results on June 10, 2026

BEIJING, June 4, 2026 /PRNewswire/ -- Cheetah Mobile Inc. ("Cheetah Mobile" or the "Company") (NYSE: CMCM), a China-based IT company with a commitment to AI innovation, today announced that it will report its financial results for the first quarter...

GAC Posts 140% Export Growth in May, Advancing Its Vision of Sustainable Global Mobility

GAC Posts 140% Export Growth in May, Advancing Its Vision of Sustainable Global Mobility

GUANGZHOU, China, June 4, 2026 /PRNewswire/ -- GAC today announced another month of accelerating global momentum, with proprietary brand exports reaching 28,386 units in May, a 140% year-on-year increase. Cumulative exports from January to May...

World's First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory Gastric Cancer and NDA Accepted by China NMPA

World's First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory Gastric Cancer and NDA Accepted by China NMPA

SAN FRANCISCO and SUZHOU, China, June 4, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...

PaidBy® by Xryma Plc, partners with Mastercard to scale cross-border account-to-account payments

PaidBy® by Xryma Plc, partners with Mastercard to scale cross-border account-to-account payments

Strategic partnership combines Mastercard's global Open Finance connectivity and scale with PaidBy®'s orchestration and settlement infrastructure to unlock international A2A payments AMSTERDAM, June 4, 2026 /PRNewswire/ -- PaidBy®, the global...

Lupeng Pharmaceutical's Fourth-Generation BTK Inhibitor Rocbrutinib Approved in China for Relapsed or Refractory Mantle Cell Lymphoma

Lupeng Pharmaceutical's Fourth-Generation BTK Inhibitor Rocbrutinib Approved in China for Relapsed or Refractory Mantle Cell Lymphoma

GUANGZHOU, China, June 4, 2026 /PRNewswire/ -- Lupeng Pharmaceutical today announced that the National Medical Products Administration (NMPA) has granted accelerated approval to rocbrutinib (development code: LP-168) for the treatment of adult...

111, Inc. Announces First Quarter 2026 Unaudited Financial Results

111, Inc. Announces First Quarter 2026 Unaudited Financial Results

Continuing Transition toward a More Asset-Light and Operationally Efficient Business Model Net Revenue of Promotional Products (1) Increased by 70.2% and Gross Profit Rose by 75.0% Year-over-Year Total Marketplace (MP) Service Revenue Increased by...

TelkomMetra Strengthens Its Business Portfolio Restructuring Strategy, AdMedika Group Ready for Distinct Expansion under Fullerton Health

TelkomMetra Strengthens Its Business Portfolio Restructuring Strategy, AdMedika Group Ready for Distinct Expansion under Fullerton Health

This strategic initiative aligns with Danantara Indonesia's streamlining directive to TelkomGroup in strengthening its structure and sharpening its business focus. JAKARTA, Indonesia, June 4, 2026 /PRNewswire/ -- PT Multimedia Nusantara...

StarCharge Unveils Next-Generation Energy Solutions and Strategic ANZ Partnership at SNEC 2026

StarCharge Unveils Next-Generation Energy Solutions and Strategic ANZ Partnership at SNEC 2026

SHANGHAI, June 4, 2026 /PRNewswire/ -- StarCharge, a global leader in EV charging and digital energy solutions, showcased its latest smart energy technologies and announced a strategic partnership with Australia's SolarJuice at SNEC 2026,...

1 ... 16 17 18 19 20 21 22 23 24 ... 4704
menu
menu